PPD Incorporation on Muck Rack

PPD Incorporation

As seen in: British Pharmacological Society
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with PPD

Contact PPD, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Pharmacology Research & Perspectives

|
By Darin Brimhall, Yu-Luan Chen, Sarah Lee, PPD Incorporation
| British Pharmacological Society
1 Introduction Relugolix is an oral gonadotropin-releasing hormone receptor antagonist that competitively binds to receptors in the anterior pituitary and leads to a reversible, dose-dependent suppression of luteinizing hormone and follicle-stimulating hormone, thereby lowering levels of sex steroid hormones such as testosterone, estradiol, and progesterone [1, 2].
Open in Who Shared Issue with article?
See all 1 articles

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Get in touch with PPD

Contact PPD, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified